Tharimmune, Inc. ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of ...
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...
The Air Quality Index (AQI) remains severe to hazardous in Delhi NCR which is a leading cause of the rise in respiratory and chest infection cases in hospitals. According to Dr Sudhir Gupta, senior ...
Chronic kidney disease (CKD) is increasingly recognized as a major global health issue, and disparities in healthcare access ...
When following a renal (kidney disease) diet, consuming foods low in sodium, phosphorus, potassium, and protein is crucial to ...
A new study found that “forever chemicals” could lead to kidney damage in young adults through dysregulations of their gut ...
When these essential organs begin to falter, they send out signals that can help us identify potential problems early on. ...
End‐stage kidney disease (ESKD) is commonly associated with critical limb‐threatening ischemia (CLTI) and frailty. Yet there are no specific tools to predict outcomes of CLTI in ESKD, particularly ...
coli O157:H7 bacteria confirmed in the outbreak. That bacteria produces a dangerous toxin that can cause a severe kidney disease complication known as hemolytic uremic syndrome, according to ...
Peking University-led researchers have modified an existing treatment for liver disease that does not cause itchiness, a common side effect of existing treatments. Chronic itch is a debilitating ...